First Encounter with SARS-CoV-2 Shapes Antibody Response to Repeated Vaccination
END-VOC researchers show that the antibody profile evolves with repeated mRNA vaccination, offering new clues about long-term protection against COVID-19 […]
END-VOC’s Legacy
As END-VOC comes to an end, this table summarises the project’s key results, who can use them, what for, and how to access them […]
Being Infected or Vaccinated First Influences COVID-19 Immunity
Using data from a healthcare worker cohort, ENDVOC researchers show that people first vaccinated show stronger antibody responses to Omicron […]
The Sequence of Previous Diseases May Help Predict the Risk of Long COVID
A study by ENDVOC researchers using the COVICAT cohort identifies risk profiles for long COVID […]
END-VOC Issues Strategic Recommendations to Strengthen Cohort-Based Research for Future Health Threats
The recommendations call on researchers, authorities and funders to ensure consistent protocols, robust infrastructure, and flexible ethical and funding mechanisms […]
